Analyzing the top 9% yield dividend growers that raise payouts regularly and also the risks to keep in mind before investing.

JPMorgan Chase delivered robust Q2 results, with net profit reaching $21.2B and EPS of $7.71, driven by strong non-interest ...

Eli Lilly has strengthened its global obesity drug market dominance, outpacing Novo Nordisk despite intensifying competition ...

Nvidia looks undervalued ahead of Q2 FY27 earnings as SpaceX's 10 GW data center plans could add $120–230B in revenue. Click ...

Rocket Lab's acquisitions, Mars projects, and a $2.36B backlog fueling growth make a case for a buy. Click here to read more ...

Diversified Royalty remains a 'Buy' with a base-case price target of $4.70, offering ~14% upside and a 6.9% yield. The Mr.

HYDB is a unique high-yield corporate bond ETF targeting above-average spreads for its credit quality—now yielding 7.0%.

Docusign looks undervalued at 14x forward P/E vs. peers at 23x after a 13% drop; strong fundamentals support a rerating.

The Metals Royalty Company presents a unique risk profile with just two assets: Mesabi iron ore and NORI deep-sea ...

Cadre Holdings earns a Hold rating at ~$34, reflecting fair value and a slight bullish lean driven by recurring revenue and ...

Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine.

AST SpaceMobile is down about 5.8% YTD while the fleet reached 13 satellites, the backlog grew, and liquidity crossed $3.7B.